世界の慢性閉塞性肺疾患（COPD）市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Chronic Obstructive Pulmonary Disease Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z1323 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、慢性閉塞性肺疾患（COPD）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（気管支拡張薬、糖質コルチコイド、その他）、用途別市場規模（予防、診断、治療）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・慢性閉塞性肺疾患（COPD）の市場動向 ・企業の競争状況、市場シェア ・慢性閉塞性肺疾患（COPD）の種類別市場規模（気管支拡張薬、糖質コルチコイド、その他） ・慢性閉塞性肺疾患（COPD）の用途別市場規模（予防、診断、治療） ・慢性閉塞性肺疾患（COPD）の北米市場規模2016-2027（アメリカ、カナダ） ・慢性閉塞性肺疾患（COPD）のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・慢性閉塞性肺疾患（COPD）のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・慢性閉塞性肺疾患（COPD）の中南米市場規模2016-2027（メキシコ、ブラジル） ・慢性閉塞性肺疾患（COPD）の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（AstraZeneca、GSK、MSD、Sunovion、Novartis、Roche Group、Pfizer、Jubilant Pharma Limited、Almirall、Horizon Pharma、Boehringer Ingelheim） ・結論

Chronic obstructive pulmonary disease (COPD) is a type of obstructive lung disease characterized by long-term breathing problems and poor airflow The main symptoms include shortness of breath and cough with sputum production. COPD is a progressive disease, meaning it typically worsens over time. Eventually everyday activities, such as walking or getting dressed, become difficult .Chronic bronchitis and emphysema are older terms used for different types of COPD.
Globally the market for COPD is increasing rapidly. The major factor that derives the growth of COPD is the increasing growth in smoking in adults. Furthermore increasing pollution in the environment and increasing asthma patients are increasing the growth of COPD market.

Market Analysis and Insights: Global Chronic Obstructive Pulmonary Disease Market
The global Chronic Obstructive Pulmonary Disease market size is projected to reach US$ 4816.6 million by 2026, from US$ 3998.2 million in 2019, at a CAGR of 2.7% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Chronic Obstructive Pulmonary Disease market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Chronic Obstructive Pulmonary Disease market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Chronic Obstructive Pulmonary Disease market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Chronic Obstructive Pulmonary Disease market.

Global Chronic Obstructive Pulmonary Disease Scope and Market Size
Chronic Obstructive Pulmonary Disease market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Chronic Obstructive Pulmonary Disease market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Bronchodilators
Glucocorticoids
Other

Segment by Application
Prevention
Diagnostic
Treatment

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
AstraZeneca
GSK
MSD
Sunovion
Novartis
Roche Group
Pfizer
Jubilant Pharma Limited
Almirall

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Chronic Obstructive Pulmonary Disease Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Bronchodilators
1.2.3 Glucocorticoids
1.2.4 Other
1.3 Market by Application
1.3.1 Global Chronic Obstructive Pulmonary Disease Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Prevention
1.3.3 Diagnostic
1.3.4 Treatment
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Chronic Obstructive Pulmonary Disease Market Perspective (2016-2027)
2.2 Chronic Obstructive Pulmonary Disease Growth Trends by Regions
2.2.1 Chronic Obstructive Pulmonary Disease Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Chronic Obstructive Pulmonary Disease Historic Market Share by Regions (2016-2021)
2.2.3 Chronic Obstructive Pulmonary Disease Forecasted Market Size by Regions (2022-2027)
2.3 Chronic Obstructive Pulmonary Disease Industry Dynamic
2.3.1 Chronic Obstructive Pulmonary Disease Market Trends
2.3.2 Chronic Obstructive Pulmonary Disease Market Drivers
2.3.3 Chronic Obstructive Pulmonary Disease Market Challenges
2.3.4 Chronic Obstructive Pulmonary Disease Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Chronic Obstructive Pulmonary Disease Players by Revenue
3.1.1 Global Top Chronic Obstructive Pulmonary Disease Players by Revenue (2016-2021)
3.1.2 Global Chronic Obstructive Pulmonary Disease Revenue Market Share by Players (2016-2021)
3.2 Global Chronic Obstructive Pulmonary Disease Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Chronic Obstructive Pulmonary Disease Revenue
3.4 Global Chronic Obstructive Pulmonary Disease Market Concentration Ratio
3.4.1 Global Chronic Obstructive Pulmonary Disease Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Chronic Obstructive Pulmonary Disease Revenue in 2020
3.5 Chronic Obstructive Pulmonary Disease Key Players Head office and Area Served
3.6 Key Players Chronic Obstructive Pulmonary Disease Product Solution and Service
3.7 Date of Enter into Chronic Obstructive Pulmonary Disease Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Chronic Obstructive Pulmonary Disease Breakdown Data by Type
4.1 Global Chronic Obstructive Pulmonary Disease Historic Market Size by Type (2016-2021)
4.2 Global Chronic Obstructive Pulmonary Disease Forecasted Market Size by Type (2022-2027)

5 Chronic Obstructive Pulmonary Disease Breakdown Data by Application
5.1 Global Chronic Obstructive Pulmonary Disease Historic Market Size by Application (2016-2021)
5.2 Global Chronic Obstructive Pulmonary Disease Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Chronic Obstructive Pulmonary Disease Market Size (2016-2027)
6.2 North America Chronic Obstructive Pulmonary Disease Market Size by Type
6.2.1 North America Chronic Obstructive Pulmonary Disease Market Size by Type (2016-2021)
6.2.2 North America Chronic Obstructive Pulmonary Disease Market Size by Type (2022-2027)
6.2.3 North America Chronic Obstructive Pulmonary Disease Market Size by Type (2016-2027)
6.3 North America Chronic Obstructive Pulmonary Disease Market Size by Application
6.3.1 North America Chronic Obstructive Pulmonary Disease Market Size by Application (2016-2021)
6.3.2 North America Chronic Obstructive Pulmonary Disease Market Size by Application (2022-2027)
6.3.3 North America Chronic Obstructive Pulmonary Disease Market Size by Application (2016-2027)
6.4 North America Chronic Obstructive Pulmonary Disease Market Size by Country
6.4.1 North America Chronic Obstructive Pulmonary Disease Market Size by Country (2016-2021)
6.4.2 North America Chronic Obstructive Pulmonary Disease Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Chronic Obstructive Pulmonary Disease Market Size (2016-2027)
7.2 Europe Chronic Obstructive Pulmonary Disease Market Size by Type
7.2.1 Europe Chronic Obstructive Pulmonary Disease Market Size by Type (2016-2021)
7.2.2 Europe Chronic Obstructive Pulmonary Disease Market Size by Type (2022-2027)
7.2.3 Europe Chronic Obstructive Pulmonary Disease Market Size by Type (2016-2027)
7.3 Europe Chronic Obstructive Pulmonary Disease Market Size by Application
7.3.1 Europe Chronic Obstructive Pulmonary Disease Market Size by Application (2016-2021)
7.3.2 Europe Chronic Obstructive Pulmonary Disease Market Size by Application (2022-2027)
7.3.3 Europe Chronic Obstructive Pulmonary Disease Market Size by Application (2016-2027)
7.4 Europe Chronic Obstructive Pulmonary Disease Market Size by Country
7.4.1 Europe Chronic Obstructive Pulmonary Disease Market Size by Country (2016-2021)
7.4.2 Europe Chronic Obstructive Pulmonary Disease Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Chronic Obstructive Pulmonary Disease Market Size (2016-2027)
8.2 Asia-Pacific Chronic Obstructive Pulmonary Disease Market Size by Type
8.2.1 Asia-Pacific Chronic Obstructive Pulmonary Disease Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Chronic Obstructive Pulmonary Disease Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Chronic Obstructive Pulmonary Disease Market Size by Type (2016-2027)
8.3 Asia-Pacific Chronic Obstructive Pulmonary Disease Market Size by Application
8.3.1 Asia-Pacific Chronic Obstructive Pulmonary Disease Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Chronic Obstructive Pulmonary Disease Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Chronic Obstructive Pulmonary Disease Market Size by Application (2016-2027)
8.4 Asia-Pacific Chronic Obstructive Pulmonary Disease Market Size by Region
8.4.1 Asia-Pacific Chronic Obstructive Pulmonary Disease Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Chronic Obstructive Pulmonary Disease Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Chronic Obstructive Pulmonary Disease Market Size (2016-2027)
9.2 Latin America Chronic Obstructive Pulmonary Disease Market Size by Type
9.2.1 Latin America Chronic Obstructive Pulmonary Disease Market Size by Type (2016-2021)
9.2.2 Latin America Chronic Obstructive Pulmonary Disease Market Size by Type (2022-2027)
9.2.3 Latin America Chronic Obstructive Pulmonary Disease Market Size by Type (2016-2027)
9.3 Latin America Chronic Obstructive Pulmonary Disease Market Size by Application
9.3.1 Latin America Chronic Obstructive Pulmonary Disease Market Size by Application (2016-2021)
9.3.2 Latin America Chronic Obstructive Pulmonary Disease Market Size by Application (2022-2027)
9.3.3 Latin America Chronic Obstructive Pulmonary Disease Market Size by Application (2016-2027)
9.4 Latin America Chronic Obstructive Pulmonary Disease Market Size by Country
9.4.1 Latin America Chronic Obstructive Pulmonary Disease Market Size by Country (2016-2021)
9.4.2 Latin America Chronic Obstructive Pulmonary Disease Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Chronic Obstructive Pulmonary Disease Market Size (2016-2027)
10.2 Middle East & Africa Chronic Obstructive Pulmonary Disease Market Size by Type
10.2.1 Middle East & Africa Chronic Obstructive Pulmonary Disease Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Chronic Obstructive Pulmonary Disease Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Chronic Obstructive Pulmonary Disease Market Size by Type (2016-2027)
10.3 Middle East & Africa Chronic Obstructive Pulmonary Disease Market Size by Application
10.3.1 Middle East & Africa Chronic Obstructive Pulmonary Disease Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Chronic Obstructive Pulmonary Disease Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Chronic Obstructive Pulmonary Disease Market Size by Application (2016-2027)
10.4 Middle East & Africa Chronic Obstructive Pulmonary Disease Market Size by Country
10.4.1 Middle East & Africa Chronic Obstructive Pulmonary Disease Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Chronic Obstructive Pulmonary Disease Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Details
11.1.2 AstraZeneca Business Overview
11.1.3 AstraZeneca Chronic Obstructive Pulmonary Disease Introduction
11.1.4 AstraZeneca Revenue in Chronic Obstructive Pulmonary Disease Business (2016-2021)
11.1.5 AstraZeneca Recent Development
11.2 GSK
11.2.1 GSK Company Details
11.2.2 GSK Business Overview
11.2.3 GSK Chronic Obstructive Pulmonary Disease Introduction
11.2.4 GSK Revenue in Chronic Obstructive Pulmonary Disease Business (2016-2021)
11.2.5 GSK Recent Development
11.3 MSD
11.3.1 MSD Company Details
11.3.2 MSD Business Overview
11.3.3 MSD Chronic Obstructive Pulmonary Disease Introduction
11.3.4 MSD Revenue in Chronic Obstructive Pulmonary Disease Business (2016-2021)
11.3.5 MSD Recent Development
11.4 Sunovion
11.4.1 Sunovion Company Details
11.4.2 Sunovion Business Overview
11.4.3 Sunovion Chronic Obstructive Pulmonary Disease Introduction
11.4.4 Sunovion Revenue in Chronic Obstructive Pulmonary Disease Business (2016-2021)
11.4.5 Sunovion Recent Development
11.5 Novartis
11.5.1 Novartis Company Details
11.5.2 Novartis Business Overview
11.5.3 Novartis Chronic Obstructive Pulmonary Disease Introduction
11.5.4 Novartis Revenue in Chronic Obstructive Pulmonary Disease Business (2016-2021)
11.5.5 Novartis Recent Development
11.6 Roche Group
11.6.1 Roche Group Company Details
11.6.2 Roche Group Business Overview
11.6.3 Roche Group Chronic Obstructive Pulmonary Disease Introduction
11.6.4 Roche Group Revenue in Chronic Obstructive Pulmonary Disease Business (2016-2021)
11.6.5 Roche Group Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Details
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Chronic Obstructive Pulmonary Disease Introduction
11.7.4 Pfizer Revenue in Chronic Obstructive Pulmonary Disease Business (2016-2021)
11.7.5 Pfizer Recent Development
11.8 Jubilant Pharma Limited
11.8.1 Jubilant Pharma Limited Company Details
11.8.2 Jubilant Pharma Limited Business Overview
11.8.3 Jubilant Pharma Limited Chronic Obstructive Pulmonary Disease Introduction
11.8.4 Jubilant Pharma Limited Revenue in Chronic Obstructive Pulmonary Disease Business (2016-2021)
11.8.5 Jubilant Pharma Limited Recent Development
11.9 Almirall
11.9.1 Almirall Company Details
11.9.2 Almirall Business Overview
11.9.3 Almirall Chronic Obstructive Pulmonary Disease Introduction
11.9.4 Almirall Revenue in Chronic Obstructive Pulmonary Disease Business (2016-2021)
11.9.5 Almirall Recent Development
11.10 Horizon Pharma
11.10.1 Horizon Pharma Company Details
11.10.2 Horizon Pharma Business Overview
11.10.3 Horizon Pharma Chronic Obstructive Pulmonary Disease Introduction
11.10.4 Horizon Pharma Revenue in Chronic Obstructive Pulmonary Disease Business (2016-2021)
11.10.5 Horizon Pharma Recent Development
11.11 Boehringer Ingelheim
11.11.1 Boehringer Ingelheim Company Details
11.11.2 Boehringer Ingelheim Business Overview
11.11.3 Boehringer Ingelheim Chronic Obstructive Pulmonary Disease Introduction
11.11.4 Boehringer Ingelheim Revenue in Chronic Obstructive Pulmonary Disease Business (2016-2021)
11.11.5 Boehringer Ingelheim Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Chronic Obstructive Pulmonary Disease Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Bronchodilators
Table 3. Key Players of Glucocorticoids
Table 4. Key Players of Other
Table 5. Global Chronic Obstructive Pulmonary Disease Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Chronic Obstructive Pulmonary Disease Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Chronic Obstructive Pulmonary Disease Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Chronic Obstructive Pulmonary Disease Market Share by Regions (2016-2021)
Table 9. Global Chronic Obstructive Pulmonary Disease Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Chronic Obstructive Pulmonary Disease Market Share by Regions (2022-2027)
Table 11. Chronic Obstructive Pulmonary Disease Market Trends
Table 12. Chronic Obstructive Pulmonary Disease Market Drivers
Table 13. Chronic Obstructive Pulmonary Disease Market Challenges
Table 14. Chronic Obstructive Pulmonary Disease Market Restraints
Table 15. Global Chronic Obstructive Pulmonary Disease Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Chronic Obstructive Pulmonary Disease Market Share by Players (2016-2021)
Table 17. Global Top Chronic Obstructive Pulmonary Disease Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chronic Obstructive Pulmonary Disease as of 2020)
Table 18. Ranking of Global Top Chronic Obstructive Pulmonary Disease Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Chronic Obstructive Pulmonary Disease Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Chronic Obstructive Pulmonary Disease Product Solution and Service
Table 22. Date of Enter into Chronic Obstructive Pulmonary Disease Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Chronic Obstructive Pulmonary Disease Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Chronic Obstructive Pulmonary Disease Revenue Market Share by Type (2016-2021)
Table 26. Global Chronic Obstructive Pulmonary Disease Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Chronic Obstructive Pulmonary Disease Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Chronic Obstructive Pulmonary Disease Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Chronic Obstructive Pulmonary Disease Revenue Market Share by Application (2016-2021)
Table 30. Global Chronic Obstructive Pulmonary Disease Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Chronic Obstructive Pulmonary Disease Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Chronic Obstructive Pulmonary Disease Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Chronic Obstructive Pulmonary Disease Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Chronic Obstructive Pulmonary Disease Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Chronic Obstructive Pulmonary Disease Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Chronic Obstructive Pulmonary Disease Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Chronic Obstructive Pulmonary Disease Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Chronic Obstructive Pulmonary Disease Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Chronic Obstructive Pulmonary Disease Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Chronic Obstructive Pulmonary Disease Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Chronic Obstructive Pulmonary Disease Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Chronic Obstructive Pulmonary Disease Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Chronic Obstructive Pulmonary Disease Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Chronic Obstructive Pulmonary Disease Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Chronic Obstructive Pulmonary Disease Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Chronic Obstructive Pulmonary Disease Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Chronic Obstructive Pulmonary Disease Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Chronic Obstructive Pulmonary Disease Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Chronic Obstructive Pulmonary Disease Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Chronic Obstructive Pulmonary Disease Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Chronic Obstructive Pulmonary Disease Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Chronic Obstructive Pulmonary Disease Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Chronic Obstructive Pulmonary Disease Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Chronic Obstructive Pulmonary Disease Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Chronic Obstructive Pulmonary Disease Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Chronic Obstructive Pulmonary Disease Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Chronic Obstructive Pulmonary Disease Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Chronic Obstructive Pulmonary Disease Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Chronic Obstructive Pulmonary Disease Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Chronic Obstructive Pulmonary Disease Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Chronic Obstructive Pulmonary Disease Market Size by Country (2022-2027) & (US$ Million)
Table 62. AstraZeneca Company Details
Table 63. AstraZeneca Business Overview
Table 64. AstraZeneca Chronic Obstructive Pulmonary Disease Product
Table 65. AstraZeneca Revenue in Chronic Obstructive Pulmonary Disease Business (2016-2021) & (US$ Million)
Table 66. AstraZeneca Recent Development
Table 67. GSK Company Details
Table 68. GSK Business Overview
Table 69. GSK Chronic Obstructive Pulmonary Disease Product
Table 70. GSK Revenue in Chronic Obstructive Pulmonary Disease Business (2016-2021) & (US$ Million)
Table 71. GSK Recent Development
Table 72. MSD Company Details
Table 73. MSD Business Overview
Table 74. MSD Chronic Obstructive Pulmonary Disease Product
Table 75. MSD Revenue in Chronic Obstructive Pulmonary Disease Business (2016-2021) & (US$ Million)
Table 76. MSD Recent Development
Table 77. Sunovion Company Details
Table 78. Sunovion Business Overview
Table 79. Sunovion Chronic Obstructive Pulmonary Disease Product
Table 80. Sunovion Revenue in Chronic Obstructive Pulmonary Disease Business (2016-2021) & (US$ Million)
Table 81. Sunovion Recent Development
Table 82. Novartis Company Details
Table 83. Novartis Business Overview
Table 84. Novartis Chronic Obstructive Pulmonary Disease Product
Table 85. Novartis Revenue in Chronic Obstructive Pulmonary Disease Business (2016-2021) & (US$ Million)
Table 86. Novartis Recent Development
Table 87. Roche Group Company Details
Table 88. Roche Group Business Overview
Table 89. Roche Group Chronic Obstructive Pulmonary Disease Product
Table 90. Roche Group Revenue in Chronic Obstructive Pulmonary Disease Business (2016-2021) & (US$ Million)
Table 91. Roche Group Recent Development
Table 92. Pfizer Company Details
Table 93. Pfizer Business Overview
Table 94. Pfizer Chronic Obstructive Pulmonary Disease Product
Table 95. Pfizer Revenue in Chronic Obstructive Pulmonary Disease Business (2016-2021) & (US$ Million)
Table 96. Pfizer Recent Development
Table 97. Jubilant Pharma Limited Company Details
Table 98. Jubilant Pharma Limited Business Overview
Table 99. Jubilant Pharma Limited Revenue in Chronic Obstructive Pulmonary Disease Business (2016-2021) & (US$ Million)
Table 100. Jubilant Pharma Limited Recent Development
Table 101. Almirall Company Details
Table 102. Almirall Business Overview
Table 103. Almirall Chronic Obstructive Pulmonary Disease Product
Table 104. Almirall Revenue in Chronic Obstructive Pulmonary Disease Business (2016-2021) & (US$ Million)
Table 105. Almirall Recent Development
Table 106. Horizon Pharma Company Details
Table 107. Horizon Pharma Business Overview
Table 108. Horizon Pharma Chronic Obstructive Pulmonary Disease Product
Table 109. Horizon Pharma Revenue in Chronic Obstructive Pulmonary Disease Business (2016-2021) & (US$ Million)
Table 110. Horizon Pharma Recent Development
Table 111. Boehringer Ingelheim Company Details
Table 112. Boehringer Ingelheim Business Overview
Table 113. Boehringer Ingelheim Chronic Obstructive Pulmonary Disease Product
Table 114. Boehringer Ingelheim Revenue in Chronic Obstructive Pulmonary Disease Business (2016-2021) & (US$ Million)
Table 115. Boehringer Ingelheim Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Chronic Obstructive Pulmonary Disease Market Share by Type: 2020 VS 2027
Figure 2. Bronchodilators Features
Figure 3. Glucocorticoids Features
Figure 4. Other Features
Figure 5. Global Chronic Obstructive Pulmonary Disease Market Share by Application: 2020 VS 2027
Figure 6. Prevention Case Studies
Figure 7. Diagnostic Case Studies
Figure 8. Treatment Case Studies
Figure 9. Chronic Obstructive Pulmonary Disease Report Years Considered
Figure 10. Global Chronic Obstructive Pulmonary Disease Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Chronic Obstructive Pulmonary Disease Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Chronic Obstructive Pulmonary Disease Market Share by Regions: 2020 VS 2027
Figure 13. Global Chronic Obstructive Pulmonary Disease Market Share by Regions (2022-2027)
Figure 14. Global Chronic Obstructive Pulmonary Disease Market Share by Players in 2020
Figure 15. Global Top Chronic Obstructive Pulmonary Disease Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chronic Obstructive Pulmonary Disease as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Chronic Obstructive Pulmonary Disease Revenue in 2020
Figure 17. Global Chronic Obstructive Pulmonary Disease Revenue Market Share by Type (2016-2021)
Figure 18. Global Chronic Obstructive Pulmonary Disease Revenue Market Share by Type (2022-2027)
Figure 19. North America Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Chronic Obstructive Pulmonary Disease Market Share by Type (2016-2027)
Figure 21. North America Chronic Obstructive Pulmonary Disease Market Share by Application (2016-2027)
Figure 22. North America Chronic Obstructive Pulmonary Disease Market Share by Country (2016-2027)
Figure 23. United States Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Chronic Obstructive Pulmonary Disease Market Share by Type (2016-2027)
Figure 27. Europe Chronic Obstructive Pulmonary Disease Market Share by Application (2016-2027)
Figure 28. Europe Chronic Obstructive Pulmonary Disease Market Share by Country (2016-2027)
Figure 29. Germany Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Chronic Obstructive Pulmonary Disease Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Chronic Obstructive Pulmonary Disease Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Chronic Obstructive Pulmonary Disease Market Share by Region (2016-2027)
Figure 39. China Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Chronic Obstructive Pulmonary Disease Market Share by Type (2016-2027)
Figure 47. Latin America Chronic Obstructive Pulmonary Disease Market Share by Application (2016-2027)
Figure 48. Latin America Chronic Obstructive Pulmonary Disease Market Share by Country (2016-2027)
Figure 49. Mexico Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Chronic Obstructive Pulmonary Disease Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Chronic Obstructive Pulmonary Disease Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Chronic Obstructive Pulmonary Disease Market Share by Country (2016-2027)
Figure 55. Turkey Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. AstraZeneca Revenue Growth Rate in Chronic Obstructive Pulmonary Disease Business (2016-2021)
Figure 59. GSK Revenue Growth Rate in Chronic Obstructive Pulmonary Disease Business (2016-2021)
Figure 60. MSD Revenue Growth Rate in Chronic Obstructive Pulmonary Disease Business (2016-2021)
Figure 61. Sunovion Revenue Growth Rate in Chronic Obstructive Pulmonary Disease Business (2016-2021)
Figure 62. Novartis Revenue Growth Rate in Chronic Obstructive Pulmonary Disease Business (2016-2021)
Figure 63. Roche Group Revenue Growth Rate in Chronic Obstructive Pulmonary Disease Business (2016-2021)
Figure 64. Pfizer Revenue Growth Rate in Chronic Obstructive Pulmonary Disease Business (2016-2021)
Figure 65. Jubilant Pharma Limited Revenue Growth Rate in Chronic Obstructive Pulmonary Disease Business (2016-2021)
Figure 66. Almirall Revenue Growth Rate in Chronic Obstructive Pulmonary Disease Business (2016-2021)
Figure 67. Horizon Pharma Revenue Growth Rate in Chronic Obstructive Pulmonary Disease Business (2016-2021)
Figure 68. Boehringer Ingelheim Revenue Growth Rate in Chronic Obstructive Pulmonary Disease Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed

---